Magnetic resonance imaging in multiple sclerosis (magnims) score predicts long-term clinical disease activity (CDA)-free status and disability progression in subcutaneous interferon beta-1a (scifnb-1a)-treated patients [5]

Authors
Category Primary study
ConferenceNeurology and Therapy
Year 2019
This article has no abstract
Epistemonikos ID: 172a55452f8e2ad475e40a6d6004852b3636e764
First added on: Apr 30, 2026